Stay updated on Cenobamate Open-Label Extension Study Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.

Latest updates to the Cenobamate Open-Label Extension Study Clinical Trial page
- Check5 days agoChange DetectedBulgarian study locations have been updated, with new cities added and existing sites removed or adjusted, including Veliko Tarnovo, Varna, Sofia, and Blagoevgrad. The recruitment status now shows completion and no longer enrolling by invitation.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded new help/navigation items to the study page (How to Read a Study Record, Common Questions, How to Join a Study) and a new Intervention/Treatment section, along with a Revision: v3.6.0 notice; removed the older Intervention / Treatment formatting and the Revision: v3.5.5 note.SummaryDifference0.3%

- Check26 days agoChange DetectedThe page revision history now shows a new revision, v3.5.5, replacing the prior v3.5.4. This indicates a minor update to the page version without altering study data or visible content.SummaryDifference0.0%

- Check48 days agoChange DetectedA new page revision entry v3.5.4 was added, replacing the previous v3.5.3. This update reflects an administrative version bump in the page's revision history.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website/version change rather than a change to the clinical study record.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Cenobamate Open-Label Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.